The selection of a local intervention, such as surgery, and radiotherapy (including chemoradiotherapy), or EGFR-TKI prescription in patients with lung cancers harboring EGFRmt following postoperative recurrence remains under debate. The gene discussed is EGFR; the disease is lung carcinoma.